|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
84,540,000 |
Market
Cap: |
346.61(M) |
Last
Volume: |
34,905,322 |
Avg
Vol: |
12,169,916 |
52
Week Range: |
$4.1 - $4.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Israel Robert J |
Sr. VP, Medical Affairs |
|
2006-05-01 |
4 |
OE |
$4.00 |
$20,000 |
D/D |
5,000 |
25,722 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-04-17 |
4 |
AS |
$24.78 |
$250,025 |
D/D |
(10,000) |
604,829 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-04-17 |
4 |
OE |
$5.33 |
$53,300 |
D/D |
10,000 |
607,329 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2006-04-03 |
4 |
D |
$25.61 |
$7,094 |
D/D |
(277) |
18,203 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2006-04-03 |
4 |
OE |
$21.77 |
$6,640 |
D/D |
305 |
18,480 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2006-04-03 |
4 |
D |
$25.61 |
$8,374 |
D/D |
(327) |
17,244 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2006-04-03 |
4 |
OE |
$21.77 |
$7,859 |
D/D |
361 |
17,571 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2006-04-03 |
4 |
D |
$25.61 |
$8,733 |
D/D |
(341) |
20,505 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2006-04-03 |
4 |
OE |
$21.77 |
$8,185 |
D/D |
376 |
20,846 |
|
- |
|
Kremer Alton B |
VP, Clinical Research |
|
2006-04-03 |
4 |
D |
$25.61 |
$14,214 |
D/D |
(555) |
7,062 |
|
- |
|
Kremer Alton B |
VP, Clinical Research |
|
2006-04-03 |
4 |
OE |
$21.77 |
$13,301 |
D/D |
611 |
7,617 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-04-03 |
4 |
AS |
$25.52 |
$258,643 |
D/D |
(10,000) |
604,829 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-04-03 |
4 |
OE |
$5.33 |
$85,736 |
D/D |
11,490 |
607,329 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-04-03 |
4 |
D |
$25.61 |
$34,727 |
D/D |
(1,356) |
604,829 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2006-04-03 |
4 |
AS |
$26.16 |
$130,780 |
D/D |
(5,000) |
20,722 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2006-04-03 |
4 |
OE |
$4.00 |
$32,800 |
D/D |
5,588 |
25,722 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2006-04-03 |
4 |
D |
$25.61 |
$13,676 |
D/D |
(534) |
20,722 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2006-04-03 |
4 |
D |
$25.61 |
$11,627 |
D/D |
(454) |
2,402 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2006-04-03 |
4 |
OE |
$21.77 |
$10,885 |
D/D |
500 |
2,856 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2006-03-20 |
4 |
AS |
$27.46 |
$54,920 |
D/D |
(2,000) |
18,135 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2006-03-20 |
4 |
OE |
$4.00 |
$8,000 |
D/D |
2,000 |
20,135 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-03-15 |
4 |
AS |
$27.00 |
$270,040 |
D/D |
(10,000) |
604,695 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-03-15 |
4 |
OE |
$5.33 |
$53,300 |
D/D |
10,000 |
614,695 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
18,080 |
604,695 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-03-01 |
4 |
AS |
$29.02 |
$290,210 |
D/D |
(10,000) |
586,615 |
|
- |
|
801 Records found
|
|
Page 24 of 33 |
|
|